Effect of Two Different Mobilization Techniques in the Treatment of Low Back Pain

October 2, 2025 updated by: Ehab Mohamed Kamel Ahmed

Effect of SNAG Versus Maitland Techniques in the Management of Non-Specific Low Back Pain

Non-specific low back pain (NSLBP) is extensively musculoskeletal conditions, where manual therapy techniques have been widely employed in its management, but their short term efficacy in chronic low back pain still need more investigations. Objective: This study aimed to discuss the SNAG versus Maitland techniques in the management of NSLBP. Methods: 60 patients with chronic NSLBP will share in the study. Sessions will be conducted 3 times per week for 4 weeks. The outcomes will be evaluated for pain by the numerical rating pain scale (NPRS), disability through Oswestry Disability Index, flexion range of motion by back range of motion device, postural stability by Biodex system will be assessed at baseline, immediately post-intervention, and at a four-week follow-up

Study Overview

Status

Not yet recruiting

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Hail, Saudi Arabia, 0000
        • University Medical Clinics
        • Contact:
          • Ehab Ahmed, Physiotherapist
          • Phone Number: +966564032363

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged 25 to 40 years.
  • Diagnosed with chronic NSLBP persisting for more than three months.
  • Pain intensity between 3 to 6 on the Visual Analog Scale (VAS) during lumbar extension in a sitting position.
  • Oswestry Disability Index (ODI) score between 20% to 40%.
  • Restriction of the movement only in flexion ROM with the ability to perform at least 40° of trunk flexion.

Exclusion Criteria:

  • Specific causes of low back pain (e.g., herniated disc, spinal stenosis).
  • History of spinal surgery or trauma.
  • Neurological deficits or systemic diseases affecting the musculoskeletal system.
  • Pregnancy.
  • Current participation in other physiotherapy programs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Maitland
Participants will receive Maitland technique therapy
The technique involves applying a sustained glide to the lumbar facet joints while the patient is in a sitting position, and the pelvic girdle will be stabilized by a belt. Then the therapist will ask the patient for active forward flexion of the spine while the pressure on the facet joint is maintained during the movement till its end
Other Names:
  • sustained natural apophyseal glide
Maitland technique therapy, which consists of passive mobilizations applied to the lumbar facet joints in an anterocranial direction while the patient is in a prone lying position
Active Comparator: SNAG
Participants will receive SNAG therapy based on the Mulligan Concept
The technique involves applying a sustained glide to the lumbar facet joints while the patient is in a sitting position, and the pelvic girdle will be stabilized by a belt. Then the therapist will ask the patient for active forward flexion of the spine while the pressure on the facet joint is maintained during the movement till its end
Other Names:
  • sustained natural apophyseal glide
Maitland technique therapy, which consists of passive mobilizations applied to the lumbar facet joints in an anterocranial direction while the patient is in a prone lying position

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale
Time Frame: 4 weeks
The NPRS will be used to evaluate the level of pain by selecting a number on a rating scale, ranging from 0 (no pain) to 10 (worst and unbearable pain).
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lumbar flexion range of motion
Time Frame: 4 weeks
Measured using a Back range of motion (BROM)
4 weeks
Functional disability
Time Frame: 4 weeks
Assessed by the Oswestry Disability Index (ODI) where according to the scale the disability will be indicated as follow: 0-4 no disability, 5-14 mild disability, 5-24 moderate disability, 25-34 severe disability, and 35-50 complete disability
4 weeks
overall stability index (OSI)
Time Frame: 4 weeks
Repositioning error evaluated through proprioceptive testing provided by the Biodex Balance System, no need for cut off) as the measurement differences will be compared.
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 5, 2025

Primary Completion (Estimated)

December 30, 2025

Study Completion (Estimated)

January 20, 2026

Study Registration Dates

First Submitted

September 9, 2025

First Submitted That Met QC Criteria

September 9, 2025

First Posted (Estimated)

September 16, 2025

Study Record Updates

Last Update Posted (Estimated)

October 7, 2025

Last Update Submitted That Met QC Criteria

October 2, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • H-2025-858

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

All the data will be obtained from the experiment is under the protection of the Scientific Research Deanship, University of Ha'il, Saudi Arabia as this project is funded from it with number RG-20 202.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Non-specific Low Back Pain (NSLBP)

Clinical Trials on SNAG

Subscribe